...Danqing Zhao; Shaoxuan Hu; Daobin Zhou; Yan Zhang; Wei Wang; Wei Zhang Introduction: The clinical implications of plasma Epstein-Barr virus (EBV) DNA in patients with peripheral T-cell lymphoma (PTCL) remain unclear. Objective: This study aimed to explore the clinical correlations of pre- and post...

...). Here, we describe a patient who presented with apparent Epstein-Barr virus (EBV)-associated immune thrombocytopenia resistant to several lines of therapies, which was in fact a form of AAT with some features of AA. He eventually responded to therapy with eltrombopag, cyclosporine A (CSA...

... pleuritis. We report the first case of Epstein-Barr virus (EBV)-positive PAL arising from a posttraumatic empyema. A 75-year-old woman with chronic posttraumatic empyema presented with a tumor, which was connected to the wall of a pyothorax in the right thoracic cavity. She had a history of trauma...

...S. Al-Humood; A. AlQallaf; S. Al-Shemmari; L. Al-Faris; B. Al-Ayadhy Epstein-Barr virus (EBV) has a pathogenic role in several lymphomas, including diffuse large B-cell lymphoma (DLBCL). EBV-associated genetic aberrations in DLBCL have not been fully characterized. The aim of this study...

... gene sequences of human herpesvirus-8 (HHV-8) and Epstein-Barr virus (EBV). Tumor cells of HIV-negative patients usually express HHV-8 gene sequences, but rarely those of EBV. We report a novel case of PEL in an HIV-negative homosexual male whose tumor cells expressed both HHV-8 and EBV gene sequences...

...Kinya Ohata; Noriko Iwaki; Takeharu Kotani; Yukio Kondo; Hirohito Yamazaki; Shinji Nakao Lymphoproliferative disorders (LPDs) are generally caused by uncontrolled B-cell proliferation induced by the Epstein-Barr virus (EBV) in the setting of impaired EBV-specific T-cell immunity, particularly when...

.... Burkitt s tumour Epstein-Barr virus Leukaemia in Burkitt s lym­ phoma Methylgreen-pyronine Abstract. A Nigerian male child presented with extensive superficial lymphadenopathy, a bleeding diathesis, and numerous tumour cells in blood and bone marrow. Further characterization of the tumour cells...

...R.J.L. Davidson; S.E. Lessels A patient who developed infectious mononucleosis while being treated for Hodgkin’s disease is presented. This pathological profile does not support the concept of a causal relationship between Epstein-Barr virus and Hodgkin’s disease. 3 3 2009 © 1977 S...

...M.M.A.C. Langenhuysen The case is presented of a patient, treated for Hodgkin’s disease, who contracted infectious mononucleosis more than 3 years later. While Epstein-Barr virus has been considered a possible etiologic factor in Hodgkin’s disease, the sequence of events reported in this case has...

...S. Yoshimoto; S. Yano; M. Yamashita; H. Taguchi; Y. Kamimura; Y. Ohtsuki; I. Miyoshi A 54-year-old man developed primary brain lymphoma after immunosuppressive treatment for immunoblastic lymphadenopathy. The lymphoma cells were positive for the Epstein-Barr virus genome and had the surface...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. CD21 Epstein-Barr virus Hairy cell leukaemia Interleukin-6 Original Paper Acta Haematol 1994;92:8-13 Takeshi Tokiokaa Yoshinori Shimamotoa Fumio Nagumob Jutaro Tadanob Masaya...

...Hiroyuki Watanabe; Msahiko Koide; Kunihiko Fukuchi; Ysushi Takagi; Shigeru Tomoyasu; Nobuyoshi Tsuruoka; Kunihide Gomi The Epstein-Barr virus (EBV) genome was detected by polymerase chain reaction (PCR) in mononuclear cells from bone marrows with diverse types of hematopoietic malignancies. Viral...

... of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) by using in situ hybridization (ISH) and also evaluated the clinical and laboratory findings according to the encountered organisms. ISH using a CMV RNA probe demonstrated infected cells in 6 out of 14 cases (43%), and ISH using an EBV EBER RNA probe demonstrated...

...Martin Simon; Bettina Borisch; Berno Heymer Patients with primary or secondary immunodeficiency are at high risk for B cell lymphoproliferative syndromes (LPS) that are generally Epstein-Barr virus (EBV)-associated. We established a cell line, termed JuWa, from an immunoblastic lymphoma...

...Young Hyeh Ko; Sanghui Park; Kihyun Kim; Seok Jin Kim; Won Seog Kim Aggressive natural killer (NK) cell leukemia (ANKL) is a prototype of an Epstein-Barr virus (EBV)-associated lymphoid malignancy, which is characterized by a fulminant clinical course and a median survival interval <2 months...

... by large blastic B cells with an association of Epstein-Barr virus. Southern blot study demonstrated the clonal rearrangement of T cell receptor β-chain gene, but not of immunoglobulin heavy chain gene. Phenotypical examination of the lymph node also revealed the predominance of CD4+ T cells in addition...

... to in the content or advertisements. CD20 Epstein-Barr virus Pyothorax-associated lymphoma THP-COP therapy Tuberculous pleuritis The term pyothorax-associated lymphoma (PAL) was proposed in 1987 [ 1 ]. Although many clinical and pathological findings of PAL have been reported, effective...

...M. Helen Huls; Cliona M. Rooney; Helen E. Heslop Immunotherapy approaches with antigen-specific cytotoxic T lymphocytes (CTLs) have proved safe and effective prophylaxis and treatment of Epstein-Barr virus (EBV)-associated lymphomas arising after bone marrow transplantation. EBV is also associated...

... is Epstein-Barr virus (EBV). EBV-associated post-transplant lymphoproliferative disorder (PTLD) is a serious complication post-solid organ transplant (SOT) or hematopoietic stem cell transplant (HSCT). The disease is essentially the result of suppression of cytotoxic T-cell function and despite various...

... Sarcoidosis CD16 CD56 CD57 Epstein-Barr virus Large granular lymphocytes (LGLs) represent a morphologically characteristic subset accounting for up to 15% of blood lymphocytes. In Wright-Giemsa-stained smears they are larger than small lymphocytes, have an indented or round nucleus and contain...